256 related articles for article (PubMed ID: 15322272)
1. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.
Bluestone JA; Tang Q
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14622-6. PubMed ID: 15322272
[TBL] [Abstract][Full Text] [Related]
2. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
[TBL] [Abstract][Full Text] [Related]
4. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
6. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
Tang Q; Henriksen KJ; Bi M; Finger EB; Szot G; Ye J; Masteller EL; McDevitt H; Bonyhadi M; Bluestone JA
J Exp Med; 2004 Jun; 199(11):1455-65. PubMed ID: 15184499
[TBL] [Abstract][Full Text] [Related]
7. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
[TBL] [Abstract][Full Text] [Related]
8. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
Setoguchi R; Hori S; Takahashi T; Sakaguchi S
J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
[TBL] [Abstract][Full Text] [Related]
10. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
[TBL] [Abstract][Full Text] [Related]
12. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
13. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
14. Suppressor T cells--they're back and critical for regulation of autoimmunity!
Chatenoud L; Salomon B; Bluestone JA
Immunol Rev; 2001 Aug; 182():149-63. PubMed ID: 11722631
[TBL] [Abstract][Full Text] [Related]
15. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
17. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
Turner MS; Kane LP; Morel PA
J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
[TBL] [Abstract][Full Text] [Related]
18. CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion.
Rigby MR; Trexler AM; Pearson TC; Larsen CP
Diabetes; 2008 Oct; 57(10):2672-83. PubMed ID: 18492787
[TBL] [Abstract][Full Text] [Related]
19. The regulation of autoimmunity through CD4+ T cells.
Hutchings P; Parish N; O'Reilly L; Dawe K; Roitt IM; Cooke A
Autoimmunity; 1993; 15 Suppl():21-3. PubMed ID: 8105991
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.
Jiang S; Lechler RI
Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
